Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maroun

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Seminars in Oncology|June 1, 1987
Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomasD J Stewart, H Hugenholtz, V DaSilva, et al.
Investigational New Drugs|November 1, 1993
Phase I pharmacokinetic study of DUP-937, a new anthrapyrazoleK Bélanger, J Jolivet, J Maroun, et al.
Cancer Treatment Reports|November 1, 1986
Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group StudyP R Band, J Maroun, K Pritchard, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 1, 1991
Enhancement of sensitivity to hyperthermia by lonidamine in human cancer cellsG P Raaphorst, M M Feeley, L Martin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1991
The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell linesG P Raaphorst, M M Feeley, C E Danjoux, et al.
Seminars in Oncology|April 1, 1990
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary reportF A Shepherd, P E Goss, J Latreille, et al.
Seminars in Oncology|December 1, 1992
A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancerW K Evans, D Stewart, D Logan, et al.
Current Oncology (Toronto, Ont.)|December 15, 2010
Consensus recommendations for the use of anti-egfr therapies in metastatic colorectal cancerC Cripps, S Gill, S Ahmed, et al.
Seminars in Oncology|February 1, 1992
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancerF A Shepherd, W K Evans, P E Goss, et al.
American Journal of Clinical Oncology|December 1, 1992
Systemic infusion versus bolus chemotherapy with 5-fluorouracil in measurable metastatic colorectal cancerB Weinerman, A Shah, A Fields, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Seminars in Oncology|June 1, 1987
Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomasD J Stewart, H Hugenholtz, V DaSilva, et al.
Investigational New Drugs|November 1, 1993
Phase I pharmacokinetic study of DUP-937, a new anthrapyrazoleK Bélanger, J Jolivet, J Maroun, et al.
Cancer Treatment Reports|November 1, 1986
Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group StudyP R Band, J Maroun, K Pritchard, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 1, 1991
Enhancement of sensitivity to hyperthermia by lonidamine in human cancer cellsG P Raaphorst, M M Feeley, L Martin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1991
The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell linesG P Raaphorst, M M Feeley, C E Danjoux, et al.
Seminars in Oncology|April 1, 1990
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary reportF A Shepherd, P E Goss, J Latreille, et al.
Seminars in Oncology|December 1, 1992
A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancerW K Evans, D Stewart, D Logan, et al.
Current Oncology (Toronto, Ont.)|December 15, 2010
Consensus recommendations for the use of anti-egfr therapies in metastatic colorectal cancerC Cripps, S Gill, S Ahmed, et al.
Seminars in Oncology|February 1, 1992
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancerF A Shepherd, W K Evans, P E Goss, et al.
American Journal of Clinical Oncology|December 1, 1992
Systemic infusion versus bolus chemotherapy with 5-fluorouracil in measurable metastatic colorectal cancerB Weinerman, A Shah, A Fields, et al.
Pageof 5